Impact of cause of death adjudication on the results of the European prostate cancer screening trial

BACKGROUND: The European Randomised Study of Prostate Cancer Screening has shown a 21% relative reduction in prostate cancer mortality at 13 years. The causes of death can be misattributed, particularly in elderly men with multiple comorbidities, and therefore accurate assessment of the underlying c...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Br J Cancer
Hlavní autoři: Walter, Stephen D, de Koning, Harry J, Hugosson, Jonas, Talala, Kirsi, Roobol, Monique J, Carlsson, Sigrid, Zappa, Marco, Nelen, Vera, Kwiatkowski, Maciej, Páez, Álvaro, Moss, Sue, Auvinen, Anssi
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2017
Témata:
Epidemiology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5220145/
https://ncbi.nlm.nih.gov/pubmed/27855442
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.378
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky